Literature DB >> 18063154

Heart failure in the twenty-first century: is it a coronary artery disease or hypertension problem?

Raghava S Velagaleti1, Ramachandran S Vasan.   

Abstract

Hypertension and coronary disease are major risk factors for the incidence and progression of heart failure. These two risk factors frequently coexist, and have additive and synergistic effects that promote both left ventricular remodeling and heart failure in the general population. The relative contributions of these two risk factors to heart failure burden in the community may vary based on age, gender, and race. In general, attribution of heart failure in the community to solely one of these two risk factors is inappropriate. Prevention of both hypertension and coronary disease is important for preventing heart failure in the twenty-first century.

Entities:  

Mesh:

Year:  2007        PMID: 18063154      PMCID: PMC2350191          DOI: 10.1016/j.ccl.2007.08.010

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  98 in total

1.  Acute heart failure syndromes: current state and framework for future research.

Authors:  Mihai Gheorghiade; Faiez Zannad; George Sopko; Liviu Klein; Ileana L Piña; Marvin A Konstam; Barry M Massie; Edmond Roland; Shari Targum; Sean P Collins; Gerasimos Filippatos; Luigi Tavazzi
Journal:  Circulation       Date:  2005-12-20       Impact factor: 29.690

2.  Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction.

Authors:  Steffen Brucks; William C Little; Tania Chao; Dalane W Kitzman; Deborah Wesley-Farrington; Sanjay Gandhi; Zakariya K Shihabi
Journal:  Am J Cardiol       Date:  2005-03-01       Impact factor: 2.778

Review 3.  Epidemiology of diastolic heart failure.

Authors:  Theophilius E Owan; Margaret M Redfield
Journal:  Prog Cardiovasc Dis       Date:  2005 Mar-Apr       Impact factor: 8.194

Review 4.  Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline.

Authors: 
Journal:  J Card Fail       Date:  2006-02       Impact factor: 5.712

5.  Clinical and genetic correlates of serum aldosterone in the community: the Framingham Heart Study.

Authors:  Sekar Kathiresan; Martin G Larson; Emelia J Benjamin; Diane Corey; Joanne M Murabito; Caroline S Fox; Peter W F Wilson; Nader Rifai; James B Meigs; Gesa Ricken; Richard P Lifton; Daniel Levy; Ramachandran S Vasan
Journal:  Am J Hypertens       Date:  2005-05       Impact factor: 2.689

6.  Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure.

Authors:  Bertram Pitt; Harvey White; Jose Nicolau; Felipe Martinez; Mihai Gheorghiade; Michael Aschermann; Dirk J van Veldhuisen; Faiez Zannad; Henry Krum; Robin Mukherjee; John Vincent
Journal:  J Am Coll Cardiol       Date:  2005-08-02       Impact factor: 24.094

7.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.

Authors:  Sharon Ann Hunt; William T Abraham; Marshall H Chin; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Mariell Jessup; Marvin A Konstam; Donna M Mancini; Keith Michl; John A Oates; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2005-09-13       Impact factor: 29.690

8.  Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.

Authors:  C Torp-Pedersen; M Møller; P E Bloch-Thomsen; L Køber; E Sandøe; K Egstrup; E Agner; J Carlsen; J Videbaek; B Marchant; A J Camm
Journal:  N Engl J Med       Date:  1999-09-16       Impact factor: 91.245

9.  Coronary atherosclerosis in end-stage idiopathic dilated cardiomyopathy: an innocent bystander?

Authors:  Alessandra Repetto; Barbara Dal Bello; Michele Pasotti; Manuela Agozzino; Mario Viganò; Catherine Klersy; Luigi Tavazzi; Eloisa Arbustini
Journal:  Eur Heart J       Date:  2005-05-25       Impact factor: 29.983

10.  Cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function.

Authors:  Sekar Kathiresan; Philimon Gona; Martin G Larson; Joseph A Vita; Gary F Mitchell; Geoffrey H Tofler; Daniel Levy; Christopher Newton-Cheh; Thomas J Wang; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Circulation       Date:  2006-02-13       Impact factor: 29.690

View more
  22 in total

1.  Atherosclerotic Burden and Heart Failure After Myocardial Infarction.

Authors:  Yariv Gerber; Susan A Weston; Maurice Enriquez-Sarano; Sheila M Manemann; Alanna M Chamberlain; Ruoxiang Jiang; Véronique L Roger
Journal:  JAMA Cardiol       Date:  2016-05-01       Impact factor: 14.676

2.  Utility of Framingham risk score in urban emergency department patients with asymptomatic hypertension.

Authors:  Aaron M Brody; John M Flack; Brian A Ference; Phillip D Levy
Journal:  Crit Pathw Cardiol       Date:  2014-09

Review 3.  Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research.

Authors:  Vikrant Rai; Poonam Sharma; Swati Agrawal; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2016-10-20       Impact factor: 3.396

4.  Coexisting Frailty, Cognitive Impairment, and Heart Failure: Implications for Clinical Care.

Authors:  Brittany Butts; Rebecca Gary
Journal:  J Clin Outcomes Manag       Date:  2015-01

5.  Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort.

Authors:  Guillermo J Pons-Estel; Luis A González; Jie Zhang; Paula I Burgos; John D Reveille; Luis M Vilá; Graciela S Alarcón
Journal:  Rheumatology (Oxford)       Date:  2009-05-19       Impact factor: 7.580

6.  Are soluble ST2 levels influenced by vitamin D and/or the seasons?

Authors: 
Journal:  Endocr Connect       Date:  2019-06-01       Impact factor: 3.335

7.  Vericiguat in combination with isosorbide mononitrate in patients with chronic coronary syndromes: The randomized, phase Ib, VISOR study.

Authors:  Michael Boettcher; Gerd Mikus; Dietmar Trenk; Hans-Dirk Düngen; Frank Donath; Nikos Werner; Mahir Karakas; Nina Besche; Dominik Schulz-Burck; Mireille Gerrits; James Hung; Corina Becker
Journal:  Clin Transl Sci       Date:  2022-03-17       Impact factor: 4.438

8.  Barnidipine Real-Life Efficacy and Tolerability in Arterial Hypertension: Results from Younger and Older Patients in the BASIC-HT Study.

Authors:  Robert Lins; Caroline De Vries
Journal:  Open Cardiovasc Med J       Date:  2017-11-17

9.  Progression of Coronary Artery Calcium and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Hooman Bakhshi; Bharath Ambale-Venkatesh; Xiaoying Yang; Mohammad R Ostovaneh; Colin O Wu; Matthew Budoff; Hossein Bahrami; Nathan D Wong; David A Bluemke; João A C Lima
Journal:  J Am Heart Assoc       Date:  2017-04-20       Impact factor: 5.501

Review 10.  Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases.

Authors:  Rajasekharreddy Pala; V T Anju; Madhu Dyavaiah; Siddhardha Busi; Surya M Nauli
Journal:  Int J Nanomedicine       Date:  2020-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.